Page last updated: 2024-08-26

alpha-glutamyltryptophan and Disease Exacerbation

alpha-glutamyltryptophan has been researched along with Disease Exacerbation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blann, A; Christodoulos, K; Deplanque, G; Ganesan, TS; Harris, AL; Jones, PH; Madhusudan, S; Talbot, DC; Wellmann, S	1
Bouchillon, K; Brown, MA; Carter, CM; Daliani, DD; Do, KA; Kim, J; Logothetis, CJ; Mao, S; Perez, CA; Thall, PF; Wang, X	1
Fomin, EA; Frolov, AV; Korochkina, OV; Kuzovatova, EE; Neumoina, MV; Shamshura, OL; Sivukhina, NI; Sorinson, SN; Zhdanov, IuE	1
Cabriales, S; Espina, BM; Gill, PS; Howard, W; Scadden, DT; Shea, K; Tulpule, A	1

Trials

3 trial(s) available for alpha-glutamyltryptophan and Disease Exacerbation

Article	Year
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma. British journal of cancer, 2004, Nov-01, Volume: 91, Issue:9 Topics: Adult; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma, Renal Cell; Dipeptides; Disease Progression; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Time Factors	2004
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies. The Prostate, 2007, Nov-01, Volume: 67, Issue:15 Topics: Adenocarcinoma; Adjuvants, Immunologic; Administration, Intranasal; Androgen Antagonists; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Dipeptides; Disease Progression; Double-Blind Method; Drug Administration Schedule; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Treatment Outcome	2007
Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:4 Topics: Administration, Intranasal; Adult; AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; CD4 Lymphocyte Count; Dipeptides; Disease Progression; Drug Administration Schedule; Endothelial Growth Factors; Fatigue; Female; Headache; HIV Protease Inhibitors; Humans; Lymphokines; Male; Middle Aged; Nausea; Paresthesia; Protein Isoforms; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000

Other Studies

1 other study(ies) available for alpha-glutamyltryptophan and Disease Exacerbation

Article	Year
[The transformation of acute viral hepatitis B into chronic]. Klinicheskaia meditsina, 1996, Volume: 74, Issue:2 Topics: Acute Disease; Adjuvants, Immunologic; Adult; Algorithms; Biomarkers; Dipeptides; Disease Progression; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Peptides; Prognosis; Recombinant Proteins; Risk Factors	1996

Article

Year

[The transformation of acute viral hepatitis B into chronic].

Klinicheskaia meditsina, 1996, Volume: 74, Issue:2

Topics: Acute Disease; Adjuvants, Immunologic; Adult; Algorithms; Biomarkers; Dipeptides; Disease Progression; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Peptides; Prognosis; Recombinant Proteins; Risk Factors

1996